Consensus recommendations for the uniform reporting of clinical trials: Report of the International Myeloma Workshop Consensus Panel 1

S. Vincent Rajkumar; Jean Luc Harousseau; Brian Durie; Kenneth C. Anderson; Meletios Dimopoulos; Robert Kyle; Joan Blade; Paul Richardson; Robert Orlowski; David Siegel; Sundar Jagannath; Thierry Facon; Hervé Avet-Loiseau; Sagar Lonial; Antonio Palumbo; Jeffrey Zonder; Heinz Ludwig; David Vesole; Orhan Sezer; Nikhil C. Munshi; Jesus San Miguel

doi:10.1182/blood-2010-10-299487

Consensus recommendations for the uniform reporting of clinical trials: Report of the International Myeloma Workshop Consensus Panel 1

S. Vincent Rajkumar, Jean Luc Harousseau, Brian Durie, Kenneth C. Anderson, Meletios Dimopoulos, Robert Kyle, Joan Blade, Paul Richardson, Robert Orlowski, David Siegel, Sundar Jagannath, Thierry Facon, Hervé Avet-Loiseau, Sagar Lonial, Antonio Palumbo, Jeffrey Zonder, Heinz Ludwig, David Vesole, Orhan Sezer, Nikhil C. MunshiJesus San Miguel

Hematology

Research output: Contribution to journal › Article › peer-review

619 Scopus citations

Abstract

It is essential that there be consistency in the conduct, analysis, and reporting of clinical trial results in myeloma. The goal of the International Myeloma Workshop Consensus Panel 1 was to develop a set of guidelines for the uniform reporting of clinical trial results in myeloma. This paper provides a summary of the current response criteria in myeloma, detailed definitions for patient populations, lines of therapy, and specific endpoints. We propose that future clinical trials in myeloma follow the guidelines for reporting results proposed in this manuscript.

Original language	English (US)
Pages (from-to)	4691-4695
Number of pages	5
Journal	Blood
Volume	117
Issue number	18
DOIs	https://doi.org/10.1182/blood-2010-10-299487
State	Published - May 5 2011

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood-2010-10-299487

Cite this

Rajkumar, S. V., Harousseau, J. L., Durie, B., Anderson, K. C., Dimopoulos, M., Kyle, R., Blade, J., Richardson, P., Orlowski, R., Siegel, D., Jagannath, S., Facon, T., Avet-Loiseau, H., Lonial, S., Palumbo, A., Zonder, J., Ludwig, H., Vesole, D., Sezer, O., ... San Miguel, J. (2011). Consensus recommendations for the uniform reporting of clinical trials: Report of the International Myeloma Workshop Consensus Panel 1. Blood, 117(18), 4691-4695. https://doi.org/10.1182/blood-2010-10-299487

Rajkumar, SV, Harousseau, JL, Durie, B, Anderson, KC, Dimopoulos, M, Kyle, R, Blade, J, Richardson, P, Orlowski, R, Siegel, D, Jagannath, S, Facon, T, Avet-Loiseau, H, Lonial, S, Palumbo, A, Zonder, J, Ludwig, H, Vesole, D, Sezer, O, Munshi, NC & San Miguel, J 2011, 'Consensus recommendations for the uniform reporting of clinical trials: Report of the International Myeloma Workshop Consensus Panel 1', Blood, vol. 117, no. 18, pp. 4691-4695. https://doi.org/10.1182/blood-2010-10-299487

@article{762963f6bc1b47efb5dab7f1c8106a25,

title = "Consensus recommendations for the uniform reporting of clinical trials: Report of the International Myeloma Workshop Consensus Panel 1",

abstract = "It is essential that there be consistency in the conduct, analysis, and reporting of clinical trial results in myeloma. The goal of the International Myeloma Workshop Consensus Panel 1 was to develop a set of guidelines for the uniform reporting of clinical trial results in myeloma. This paper provides a summary of the current response criteria in myeloma, detailed definitions for patient populations, lines of therapy, and specific endpoints. We propose that future clinical trials in myeloma follow the guidelines for reporting results proposed in this manuscript.",

author = "Rajkumar, {S. Vincent} and Harousseau, {Jean Luc} and Brian Durie and Anderson, {Kenneth C.} and Meletios Dimopoulos and Robert Kyle and Joan Blade and Paul Richardson and Robert Orlowski and David Siegel and Sundar Jagannath and Thierry Facon and Herv{\'e} Avet-Loiseau and Sagar Lonial and Antonio Palumbo and Jeffrey Zonder and Heinz Ludwig and David Vesole and Orhan Sezer and Munshi, {Nikhil C.} and {San Miguel}, Jesus",

year = "2011",

month = may,

day = "5",

doi = "10.1182/blood-2010-10-299487",

language = "English (US)",

volume = "117",

pages = "4691--4695",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "18",

}

TY - JOUR

T1 - Consensus recommendations for the uniform reporting of clinical trials

T2 - Report of the International Myeloma Workshop Consensus Panel 1

AU - Rajkumar, S. Vincent

AU - Harousseau, Jean Luc

AU - Durie, Brian

AU - Anderson, Kenneth C.

AU - Dimopoulos, Meletios

AU - Kyle, Robert

AU - Blade, Joan

AU - Richardson, Paul

AU - Orlowski, Robert

AU - Siegel, David

AU - Jagannath, Sundar

AU - Facon, Thierry

AU - Avet-Loiseau, Hervé

AU - Lonial, Sagar

AU - Palumbo, Antonio

AU - Zonder, Jeffrey

AU - Ludwig, Heinz

AU - Vesole, David

AU - Sezer, Orhan

AU - Munshi, Nikhil C.

AU - San Miguel, Jesus

PY - 2011/5/5

Y1 - 2011/5/5

N2 - It is essential that there be consistency in the conduct, analysis, and reporting of clinical trial results in myeloma. The goal of the International Myeloma Workshop Consensus Panel 1 was to develop a set of guidelines for the uniform reporting of clinical trial results in myeloma. This paper provides a summary of the current response criteria in myeloma, detailed definitions for patient populations, lines of therapy, and specific endpoints. We propose that future clinical trials in myeloma follow the guidelines for reporting results proposed in this manuscript.

AB - It is essential that there be consistency in the conduct, analysis, and reporting of clinical trial results in myeloma. The goal of the International Myeloma Workshop Consensus Panel 1 was to develop a set of guidelines for the uniform reporting of clinical trial results in myeloma. This paper provides a summary of the current response criteria in myeloma, detailed definitions for patient populations, lines of therapy, and specific endpoints. We propose that future clinical trials in myeloma follow the guidelines for reporting results proposed in this manuscript.

UR - http://www.scopus.com/inward/record.url?scp=79955977910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955977910&partnerID=8YFLogxK

U2 - 10.1182/blood-2010-10-299487

DO - 10.1182/blood-2010-10-299487

M3 - Article

C2 - 21292775

AN - SCOPUS:79955977910

SN - 0006-4971

VL - 117

SP - 4691

EP - 4695

JO - Blood

JF - Blood

IS - 18

ER -

Consensus recommendations for the uniform reporting of clinical trials: Report of the International Myeloma Workshop Consensus Panel 1

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this